Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.

Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G.

Gynecol Oncol. 2012 Feb;124(2):192-8. doi: 10.1016/j.ygyno.2011.09.039. Epub 2011 Oct 29.

2.

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K.

Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43. Epub 2005 Dec 12.

3.

Digital genomic quantification of tumor-infiltrating lymphocytes.

Robins HS, Ericson NG, Guenthoer J, O'Briant KC, Tewari M, Drescher CW, Bielas JH.

Sci Transl Med. 2013 Dec 4;5(214):214ra169. doi: 10.1126/scitranslmed.3007247.

4.

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.

Tomsová M, Melichar B, Sedláková I, Steiner I.

Gynecol Oncol. 2008 Feb;108(2):415-20. Epub 2007 Nov 26.

PMID:
18037158
5.

Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.

Mhawech-Fauceglia P, Wang D, Ali L, Lele S, Huba MA, Liu S, Odunsi K.

Cancer Immun. 2013;13:1. Epub 2013 Jan 15.

6.

CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.

Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, Nelson BH.

Clin Cancer Res. 2012 Jun 15;18(12):3281-92. doi: 10.1158/1078-0432.CCR-12-0234. Epub 2012 May 2.

7.

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

Bachmayr-Heyda A, Aust S, Heinze G, Polterauer S, Grimm C, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Pils D, Schuster E, Thalhammer T, Horvat R, Denkert C, Zeillinger R, Castillo-Tong DC.

BMC Cancer. 2013 Sep 17;13:422. doi: 10.1186/1471-2407-13-422.

8.

Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis.

Jia Q, Yang Y, Wan Y.

Int J Clin Exp Med. 2015 Feb 15;8(2):1803-13. eCollection 2015.

9.

Tumor infiltrating lymphocytes in ovarian cancer.

Santoiemma PP, Powell DJ Jr.

Cancer Biol Ther. 2015;16(6):807-20. doi: 10.1080/15384047.2015.1040960. Epub 2015 Apr 20. Review.

10.

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG, Daemen T, Nijman HW.

Cancer Immunol Immunother. 2009 Mar;58(3):449-59. doi: 10.1007/s00262-008-0583-5. Epub 2008 Sep 13.

PMID:
18791714
11.

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes.

Milne K, Alexander C, Webb JR, Sun W, Dillon K, Kalloger SE, Gilks CB, Clarke B, Köbel M, Nelson BH.

J Transl Med. 2012 Feb 27;10:33. doi: 10.1186/1479-5876-10-33.

12.

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.

Santin AD, Bellone S, Palmieri M, Bossini B, Cane' S, Bignotti E, Roman JJ, Cannon MJ, Pecorelli S.

Int J Gynecol Cancer. 2004 Jan-Feb;14(1):64-75.

PMID:
14764031
13.

Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.

Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ Jr, Feldman MD, Coukos G.

Cancer Biol Ther. 2011 Aug 15;12(4):367-77. Epub 2011 Aug 15.

14.

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.

Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, Huntsman DG, Coukos G, Gilks CB.

Mod Pathol. 2009 Mar;22(3):393-402. doi: 10.1038/modpathol.2008.191. Epub 2008 Dec 5.

15.

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW.

Br J Cancer. 2011 Jun 28;105(1):93-103. doi: 10.1038/bjc.2011.189. Epub 2011 May 31. Review.

16.

Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy.

Tsiatas ML, Gyftaki R, Liacos C, Politi E, Rodolakis A, Dimopoulos MA, Bamias A.

Int J Gynecol Cancer. 2009 Nov;19(8):1329-34. doi: 10.1111/IGC.0b013e3181b7a40e.

PMID:
20009885
17.

Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells.

Ioannides CG, Freedman RS, Platsoucas CD, Rashed S, Kim YP.

J Immunol. 1991 Mar 1;146(5):1700-7.

PMID:
1704404
18.

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.

Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP.

Gynecol Obstet Invest. 2001;51(4):254-61.

PMID:
11408737
19.

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression.

Liu M, Matsumura N, Mandai M, Li K, Yagi H, Baba T, Suzuki A, Hamanishi J, Fukuhara K, Konishi I.

Mod Pathol. 2009 Mar;22(3):373-84. doi: 10.1038/modpathol.2008.187. Epub 2008 Nov 7.

20.

[Prognostic value of T lymphocytes infiltration in breast cancer].

Yu HM, Jiao SC, Yang JL, Wang JD.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):199-206. doi: 10.3881/j.issn.1000-503X.2013.02.013. Chinese.

Items per page

Supplemental Content

Write to the Help Desk